In the swiftly evolving field of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for developing productive solutions. Just about the most promising methods is the use of in vitro bystander result assays, which Engage in a pivotal role in improving therapeutic efficacy. These assays, furnish